We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current VCYT market cap is 1.72B. The company's latest EPS is USD -0.9733 and P/E is -23.16.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 82.42M | 90.32M | 90.11M | 98.2M | 96.84M |
| Operating Income | -10.5M | -8.05M | -31.74M | -34.06M | -4.23M |
| Net Income | -8.09M | -8.4M | -29.62M | -28.29M | -1.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 120.37M | 117.48M | 219.51M | 296.54M | 361.05M |
| Operating Income | -15.13M | -35.39M | -81.9M | -41.08M | -84.35M |
| Net Income | -12.6M | -34.91M | -75.56M | -36.56M | -74.4M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.16B | 1.16B | 1.12B | 1.11B | 1.2B |
| Total Liabilities | 75.86M | 78.4M | 70.88M | 70.8M | 81.42M |
| Total Equity | 1.08B | 1.08B | 1.05B | 1.04B | 1.12B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 275.21M | 457.16M | 1.19B | 1.16B | 1.11B |
| Total Liabilities | 35.76M | 35.93M | 91.31M | 81.22M | 70.8M |
| Total Equity | 239.46M | 421.23M | 1.1B | 1.08B | 1.04B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.17M | 14.5M | 28.67M | 44.22M | -8.97M |
| Investing | 24.08M | 20.41M | 17.61M | 15.11M | 2.88M |
| Financing | 1.69M | 2.08M | 2.19M | 2.84M | -864k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.23M | -9.71M | -31.62M | 7.54M | 44.22M |
| Investing | -42.73M | -3.84M | -739.21M | -29.39M | 15.11M |
| Financing | 127.29M | 203.6M | 596.32M | 3.49M | 2.84M |
| Market Cap | 1.72B |
| Price to Earnings Ratio | -23.16 |
| Price to Sales Ratio | 4.77 |
| Price to Cash Ratio | 7.96 |
| Price to Book Ratio | 1.65 |
| Dividend Yield | - |
| Shares Outstanding | 76.45M |
| Average Volume (1 week) | 730.2k |
| Average Volume (1 Month) | 643.6k |
| 52 Week Change | -13.27% |
| 52 Week High | 30.52 |
| 52 Week Low | 18.61 |
| Spread (Intraday) | 1.89 (7.87%) |
| Company Name | Veracyte Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.veracyte.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
